Ipsen Initiates a Share Buy-Back Program to Partially Cover Its Restricted Share Plans

Published: Nov 06, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARIS--(BUSINESS WIRE)--Regulatory News:

Ipsen (Euronext: IPN; ADR: IPSEY) (Paris:IPN) today announced it has granted Natixis a mandate to purchase 800 000 shares, or 0.95% of the capital. This mandate begins on 6 November 2013 and will end on 6 May 2014. The purchased shares will be cancelled.

This program is part of the authorization granted by the Combined Shareholder’s meeting held on 31 May 2013. The renewal of the authorization is subject to approval by the 2014 Combined Shareholder’s meeting of Ipsen S.A.

Help employers find you! Check out all the jobs and post your resume.

Back to news